IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 96

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: THE COMPARATIVE STUDY OF BRANDED DRUGS AND GENERIC DRUGS FOR THE TREATMENT OF HYPERTENSION
Authors Name: Miss. Shatabdi B. Roy , Ms. Chitralekha G. Therkar , Ms. Priyanka R. Boratwar , Ms. Bhagyashri R. Latare , Mr. Tushar D. Jibhkate
Download E-Certificate: Download
Author Reg. ID:
IJNRD_219075
Published Paper Id: IJNRD2404561
Published In: Volume 9 Issue 4, April-2024
DOI:
Abstract: The comparative study on some data of drug to attain the good efficacy product to the both category of people i.e. economically rich and weaker people for their healthy life is provided. The disease taken for the study of comparison is Hypertension with its treatment. According to that, there are various branded drugs are available in the market by different manufacturers with same drug composition. And from which the pharmacological parameters and products are called ‘Branded’ and then the next of that i.e. mimicry of brand called ‘Generic’ which are cheaper but similarly effective.
Keywords: Hypertension, Implicit Association, Antihypertensive
Cite Article: "THE COMPARATIVE STUDY OF BRANDED DRUGS AND GENERIC DRUGS FOR THE TREATMENT OF HYPERTENSION", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 4, page no.f497-f509, April-2024, Available :http://www.ijnrd.org/papers/IJNRD2404561.pdf
Downloads: 00030
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2404561
Registration ID: 219075
Published In: Volume 9 Issue 4, April-2024
DOI (Digital Object Identifier):
Page No: f497-f509
Country: Warora, Chandrapur, Maharashtra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2404561
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2404561
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD